- Home
- CSPI vs NVCT Comparison
CSPI vs NVCT Comparison
Compare CSPI & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSPI
- NVCT
- Stock Information
- Founded
- CSPI 1968
- NVCT 2020
- Country
- CSPI United States
- NVCT United States
- Employees
- CSPI N/A
- NVCT N/A
- Industry
- CSPI EDP Services
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- CSPI Technology
- NVCT Health Care
- Exchange
- CSPI Nasdaq
- NVCT Nasdaq
- Market Cap
- CSPI 128.4M
- NVCT 119.4M
- IPO Year
- CSPI 1987
- NVCT 2022
- Fundamental
- Price
- CSPI $12.91
- NVCT $4.95
- Analyst Decision
- CSPI
- NVCT Strong Buy
- Analyst Count
- CSPI 0
- NVCT 1
- Target Price
- CSPI N/A
- NVCT $21.00
- AVG Volume (30 Days)
- CSPI 16.2K
- NVCT 320.8K
- Earning Date
- CSPI 12-10-2024
- NVCT 11-05-2024
- Dividend Yield
- CSPI 0.93%
- NVCT N/A
- EPS Growth
- CSPI N/A
- NVCT N/A
- EPS
- CSPI 0.27
- NVCT N/A
- Revenue
- CSPI $57,512,000.00
- NVCT N/A
- Revenue This Year
- CSPI N/A
- NVCT N/A
- Revenue Next Year
- CSPI N/A
- NVCT N/A
- P/E Ratio
- CSPI $47.35
- NVCT N/A
- Revenue Growth
- CSPI N/A
- NVCT N/A
- 52 Week Low
- CSPI $8.22
- NVCT $4.83
- 52 Week High
- CSPI $29.93
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- CSPI 52.22
- NVCT 35.48
- Support Level
- CSPI $12.41
- NVCT $6.00
- Resistance Level
- CSPI $13.00
- NVCT $11.80
- Average True Range (ATR)
- CSPI 0.47
- NVCT 1.23
- MACD
- CSPI 0.03
- NVCT -0.27
- Stochastic Oscillator
- CSPI 76.32
- NVCT 1.72
About CSPI CSP Inc.
CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.